Coleman Lannum | Senior Vice President, Investor Relations |
Bryan Hanson | President and Chief Executive Officer |
Daniel Florin | Executive Vice President and Chief Financial Officer |
Robbie Marcus | J.P. Morgan Securities LLC |
Matthew Taylor | UBS Securities, LLC |
Pito Chickering | Deutsche Bank |
Vijay Kumar | Evercore ISI |
Steven Lichtman | Oppenheimer & Co. Inc. |
Josh Jennings | Cowen and Company, LLC |
Chris Pasquale | Guggenheim Securities, LLC |
Craig Bijou | Cantor Fitzgerald |
Larry Keusch | Raymond James & Associates, Inc. |
Bob Hopkins | Bank of America Merrill Lynch |
Frederick Wise | Stifel, Nicolaus & Company, Incorporated |
David Lewis | Morgan Stanley & Co. LLC |
Lawrence Biegelsen | Wells Fargo Securities, LLC |
Kristen Stewart | Barclays |
Jeff Johnson | Robert W. Baird & Co. |
Kyle Rose | Canaccord Genuity Inc. |
Richard Newitter | Leerink Partners LLC |
Michael Matson | Needham & Company, LLC |
Good morning, ladies and gentlemen, and welcome to the Zimmer Biomet First Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, April 26, 2019.
Following today's presentation, there will be a question and answer session. At this time, all participants are in a listen-only mode. [Operator Instructions] I would now like to turn the conference over to Cole Lannum, Senior Vice President, Investor Relations and IRO.